Rare diseases
Investigational molecules
Locations
Back to Spain549 clinical trials in Zaragoza, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis
SpainSpainStudy on Extended Access to Momelotinib for Patients with Myelofibrosis
SpainStudy of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
SpainStudy on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function
SpainStudy of Pembrolizumab and Olaparib for Patients with Advanced Colorectal Cancer with DNA Repair Deficiency
SpainStudy of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer
SpainStudy on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection
SpainStudy of CLR 131 for Patients with Relapsed or Refractory Waldenstrom Macroglobulinemia
SpainStudy on the Effects of Pemafibrate and Tofogliflozin in Patients with Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis
SpainStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
SpainStudy on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on advanced cancer treatments and blood disorders, including studies of new therapies for lung cancer, pancreatic adenocarcinoma, and various hematologic malignancies.
Multiple trials evaluating combination therapies and novel treatment approaches for both solid tumors and blood cancers.
Research into treatments for various inflammatory and autoimmune disorders, with emphasis on chronic conditions affecting quality of life.
Studies focusing on innovative biological therapies and targeted treatments for inflammatory conditions.
Studies addressing critical cardiovascular health challenges and metabolic conditions, including innovative approaches to stroke treatment and lipid management.
Focus on developing new therapeutic options for both acute and chronic cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
